Numinus CEO Payton Nyquvest Answers Investor Questions And Gives Look-Ahead Outlook For 2023 Dec 30, 2022
Psilocybin Therapy For Autism-Like Disorder Receives Approval For Phase 2a Clinical Trial Dec 28, 2022